Automated Breast Ultrasound Systems (ABUS) Market accounted for US$ 1.74 billion in 2022 and is estimated to be US$ 8.52 billion by 2032 and is anticipated to register a CAGR of 17.4% from 2032 to 2032
Automated Breast Ultrasound Systems (ABUS) Market Overview:
Definition:
Automated Breast Ultrasound Systems (ABUS) are medical imaging devices designed to perform ultrasound imaging of the breast. ABUS is often used as a supplementary imaging tool in addition to mammography for breast cancer screening, particularly in women with dense breast tissue.
Key Aspects:
- Breast Cancer Screening: ABUS is utilized for breast cancer screening, especially in cases where mammography may be less effective due to dense breast tissue, which can make it challenging to detect abnormalities.
- 3D Ultrasound Imaging: ABUS systems typically provide 3D ultrasound images of the entire breast, offering a more comprehensive view compared to traditional 2D ultrasound.
- Improved Sensitivity: ABUS is known for its ability to improve sensitivity in detecting breast cancer lesions, especially in women with dense breast tissue, where mammography may have limitations.
Market Drivers:
- Dense Breast Tissue Awareness: Growing awareness of the limitations of mammography in women with dense breast tissue has increased the demand for supplementary imaging modalities like ABUS.
- Advancements in Imaging Technology: Ongoing advancements in ultrasound imaging technology, including improvements in image resolution and automation features, contribute to the adoption of ABUS.
- Breast Cancer Incidence: The global incidence of breast cancer continues to drive the demand for advanced screening and diagnostic tools, with ABUS positioned as an adjunctive screening option.
Trends:
- Integration with Breast Tomosynthesis: The integration of ABUS with other imaging modalities, such as digital breast tomosynthesis (DBT), is a trend aimed at providing a more comprehensive approach to breast cancer screening.
- AI Integration: The exploration of artificial intelligence (AI) and machine learning algorithms for image interpretation and analysis is a growing trend in enhancing the efficiency and accuracy of ABUS.
Challenges:
- Cost Considerations: The cost of ABUS equipment and examinations may pose a challenge to widespread adoption, and reimbursement policies can impact accessibility.
- Radiologist Training: Adequate training for radiologists to interpret ABUS images effectively is essential for optimal use and accurate diagnosis.
- Standardization and Guidelines: Standardizing protocols and establishing clear guidelines for the use of ABUS in breast cancer screening can be challenging but is crucial for consistency in practice.
Click Here, To Get Free Sample Report https://stringentdatalytics.com/sample-request/automated-breast-ultrasound-systems-(abus)-market/11295/
Market Segmentations:
Global Automated Breast Ultrasound Systems (ABUS) Market: By Company
- GE Healthcare
- Hitachi
- Koninklijke Philips N.V.
- Siemens
- SonoCine
- QView Medical
- Seno Medical Instruments
- Volpara Solutions
- Delphinus Medical Technologies
- CapeRay
- SuperSonic Imagine
- Nova Medical Imaging TechnologyLtd.
- Shantou Institute of Ultrasonic Instruments (SIUI)
- Theraclion
- Real Imaging
- MetriTrack
- Toshiba Company
Market: By Type
- Automated Breast Ultrasound Systems(ABUS)
- Automated Breast Volume Scanner (ABVS)
Market: By Application
- Hosptials
- Diagnostic Imaging Centers
- Others
Market: Regional Analysis
The regional analysis of the global Automated Breast Ultrasound Systems (ABUS) market provides insights into the market’s performance across different regions of the world. The analysis is based on recent and future trends and includes market forecast for the prediction period. The countries covered in the regional analysis of the Automated Breast Ultrasound Systems (ABUS) market report are as follows:
North America: The North America region includes the U.S., Canada, and Mexico. The U.S. is the largest market for Automated Breast Ultrasound Systems (ABUS) in this region, followed by Canada and Mexico. The market growth in this region is primarily driven by the presence of key market players and the increasing demand for the product.
Europe: The Europe region includes Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe. Germany is the largest market for Automated Breast Ultrasound Systems (ABUS) in this region, followed by the U.K. and France. The market growth in this region is driven by the increasing demand for the product in the automotive and aerospace sectors.
Asia-Pacific: The Asia-Pacific region includes Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, and Rest of Asia-Pacific. China is the largest market for Automated Breast Ultrasound Systems (ABUS) in this region, followed by Japan and India. The market growth in this region is driven by the increasing adoption of the product in various end-use industries, such as automotive, aerospace, and construction.
Middle East and Africa: The Middle East and Africa region includes Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of Middle East and Africa. The market growth in this region is driven by the increasing demand for the product in the aerospace and defense sectors.
South America: The South America region includes Argentina, Brazil, and Rest of South America. Brazil is the largest market for Automated Breast Ultrasound Systems (ABUS) in this region, followed by Argentina. The market growth in this region is primarily driven by the increasing demand for the product in the automotive sector.
The report has helped our clients:
- To describe and forecast the Market size, on the basis of various segmentations and geography, in terms of value and volume
- To measure the changing needs of customers/industries
- To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the growth of the Market
- To gain competitive intelligence and uncover new opportunities
- To analyse opportunities in the Market for stakeholders by identifying high-growth segments in Market
- To strategically profile key players and provide details of the current competitive landscape
- To analyse strategic approaches adopted by players in the Market, such as product launches and developments, acquisitions, collaborations, contracts, expansions, and partnerships
Click Here, To Buy Premium Report https://stringentdatalytics.com/purchase/automated-breast-ultrasound-systems-(abus)-market/11295/?license=single
Frequently Asked Questions About This Report
- How big is the Market?
- What is the Market growth?
- Which segment accounted for the largest Market share?
- Who are the key companies/players in the Market?
- What are the factors driving the Market?
- How has the Covid-19 pandemic affected the Market?
- What is the leading solution segment in the Market?
- What is the leading deployment segment in the Market?
- Which enterprise segment accounted for the largest revenue share in the Market?
About Stringent Datalytics
Stringent Datalytics offers both custom and syndicated market research reports. Custom market research reports are tailored to a specific client’s needs and requirements. These reports provide unique insights into a particular industry or market segment and can help businesses make informed decisions about their strategies and operations.
Syndicated market research reports, on the other hand, are pre-existing reports that are available for purchase by multiple clients. These reports are often produced on a regular basis, such as annually or quarterly, and cover a broad range of industries and market segments. Syndicated reports provide clients with insights into industry trends, market sizes, and competitive landscapes. By offering both custom and syndicated reports, Stringent Datalytics can provide clients with a range of market research solutions that can be customized to their specific needs.
Contact Us
Stringent Datalytics
Contact No- +1 346 666 6655
Email Id- sales@stringentdatalytics.com
Leave a Reply